KRAS and lung adenocarcinoma: To further confirm the translational relevance of our findings, a patient-derived TP53/KRAS-mutated lung adenocarcinoma xenograft was tested for the ability to upregulate IFN-I pathway and Trex1 gene expression in response to hypofractionated versus high single dose radiation.